Literature DB >> 16402924

Breast cyst fluids increase the proliferation of breast cell lines in correlation with their hormone and growth factor concentration.

Pablo J Enriori1, Stella Maris Vázquez, Violeta Chiauzzi, Cecilia Pérez, Carlos R Fischer, Jorge R Gori, Alberto E Etkin, Eduardo Charreau, Ricardo S Calandra, Isabel A Lüthy.   

Abstract

OBJECTIVE AND
DESIGN: Gross cystic disease (GCD) of the breast is reported to occur in 7% of women in the developed world and, although not premalignant, is thought to be associated with an increased risk of breast cancer. Hormone and growth factor concentration levels were measured in breast cyst fluid (BCF) to correlate them with their mitogenic activity in tumour (MCF-7) or nontransformed (MCF-10A) cells.
RESULTS: Oestradiol (E2), oestrone (E1), E2-sulfate (E2-S), E1-sulfate (E1-S) and epidermal growth factor (EGF) concentrations were, as expected, significantly higher in type I than in type II cysts, while transforming growth factor-beta 2 (TGF-beta2) showed higher levels in type II cysts. Fifty per cent of the BCF samples stimulated [3H]-thymidine incorporation into MCF-7 cells while 34.5% inhibited this parameter. In MCF-10A cells, most BCF samples were stimulatory (85%). E2, E1 and EGF concentrations in BCF samples correlated significantly and positively with cell proliferation in MCF-7 cells, whereas a significant negative correlation was found for TGF-beta2. In MCF-10A cells, only E2-S and E1-S exhibited significant positive correlation, whereas a significant negative correlation was found for TGF-beta2. Progesterone (Pg), E2 and EGF incubated under the same conditions had a stimulatory effect on [3H]-thymidine incorporation into MCF-7 cells, whereas TGF-beta2 inhibited this parameter. Pg, E2, E1 and EGF significantly stimulated this parameter in MCF-10A cells.
CONCLUSIONS: The stimulatory action of BCF on cell proliferation in a model of human breast epithelial cells could partly explain the increased incidence of breast cancer in cyst-bearing women.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16402924     DOI: 10.1111/j.1365-2265.2005.02408.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  2 in total

1.  The combined influence of multiple sex and growth hormones on risk of postmenopausal breast cancer: a nested case-control study.

Authors:  Shelley S Tworoger; Bernard A Rosner; Walter C Willett; Susan E Hankinson
Journal:  Breast Cancer Res       Date:  2011-10-21       Impact factor: 6.466

2.  EGF receptor stimulation shifts breast cancer cell glucose metabolism toward glycolytic flux through PI3 kinase signaling.

Authors:  Kyung-Ho Jung; Eun Jeong Lee; Jin Won Park; Jin Hee Lee; Seung Hwan Moon; Young Seok Cho; Kyung-Han Lee
Journal:  PLoS One       Date:  2019-09-18       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.